Clinical research6 min read
· Mir
Investigator responsibilities under 21 CFR 312: what changes
FDA plans a December 2026 proposal to rewrite investigator responsibilities in 21 CFR 312 subpart D. Today's duties, the record for each, and what FDA has said.
